The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

Journal of Leukocyte Biology

Volumn 97, Issue 1, 2015, Pages 49-59

  Teodosio, Cristina ^a   Mayado, Andrea ^a   Sánchez Muñoz, Laura ^b   Morgado, José M ^b   Jara Acevedo, María ^a   Álvarez Twose, Ivan ^b   García Montero, Ándrés C ^a   Matito, Almudena ^b   Caldas, Caldas ^a   Escribano, Luis ^a   Orfao, Alberto ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Flow cytometry; Maturation activation classification prognosis

Indexed keywords

DIFFERENTIATION INDUCING FACTOR;

ARTICLE; CELL ADHESION; CELL MATURATION; EX VIVO STUDY; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; LIGHT SCATTERING; MAST CELL; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; SYSTEMIC MASTOCYTOSIS; ANIMAL; IMMUNOLOGY; MASTOCYTOSIS, SYSTEMIC;

ANIMALS; HUMANS; IMMUNOPHENOTYPING; MAST CELLS; MASTOCYTOSIS, SYSTEMIC;

EID: 84925287067     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5RU0614-296R     Document Type: Article

References (69)

1. Moon, T. C., St Laurent, C. D., Morns, K. E., Marcet, C., Yoshimura, T., Sekar, Y., Befus, A. D. (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol. 3, 111-128.
2. Rao, K. N., Brown, M. A. (2008) Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. N. Y. Arad. Sci. 1143, 83-104.
3. Horny, H. P., Metcalfe D. D., Bennett, J. M., Bain, B. J., Akin, C., Escribano, L., Valent, P. (2008) Mastocytosis. World Health Organization (WHO) classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In World Health Organization (WHO) Classification of Tumours. Pathology and Genetics of tumours of Haematopoietic and Lymphoid Tissues (S. H. Swerdlow, E. Campo, N. L. Harris, E. S.Jaffe, S. A. Pileri, H. Stein, J. Thiele, J. W. Vardiman, eds.), International Agency for Research on Cancer (IARC), Lyon, France, 54-63.
4. Garcia-Montero, A. C., Jara-Acevedo, M., Teodosio, C., Sanchez, M. L., Nunez, R., Prados, A., Aldanondo, I., Sanchez, L., Dominguez, M., Botana, L. M., Sanchez-Jimenez, F., Sotlar, K., Almeida, J., Escribano, L., Orfao, A. (2006) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108, 2366-2372.
5. Quintás-Cardama, A., Jain, N., Verstovsek, S. (2011) Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis. Cancer 117, 5439-5449.
6. Escribano, L., Garcia-Montero, A., Sanchez-Muñoz, L., Teodosio, C., Alvarez-Twose, I., Jara-Acevedo, M., Morgado,J. M., Almeida,J., Orfao, A. (2012) Diagnosis of adult mastocytosis. Role for bone marrow analysis. In Laboratory Hematology Practice, (K Kottke-Marchant, B. H. Davis, eds.), Wiley-Blackwell, Hoboken, NJ, USA, 388-398.
7. Morgado, J. M., Perbellini, O., Johnson, R. C., Teodosio, C., Matito, A., Álvarez-Twose, I., Bonadonna, P., Zamò, A., Jara-Acevedo, M., Mayado, A., Garcia-Montero, A., Mollejo, M., George, T. I., Zanotti, R., Orfao, A., Escribano, L., Sánchez-Muñoz, L. (2013) CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology 63, 780-787.
8. Morgado, J. M., Sánchez-Muñoz, L., Teodosio, C. G., Jara-Acevedo, M., Alvarez-Twose, I., Matito, A., Fernández-Nuñez, E., Garcia-Montero, A., Orfao, A., Escribano, L. (2012) Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion. Mod. Pathol. 25, 516-521.
9. Teodosio, C., Garcia-Montero, A. C., Jara-Acevedo, M., Alvarez-Twose, I., Sánchez-Muñoz, L., Almeida, J., Morgado, J. M., Matito, A., Escribano, L., Orfao, A. (2012) An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis. Leukemia 26, 951-958.
10. Teodosio, C., Garcia-Montero, A. C., Jara-Acevedo, M., Sanchez-Munoz, L., Alvarez-Twose, I., Nunez, R., Schwartz, L. B., Walls, A. F., Escribano, L., Orfao, A. (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J. Allergy Clin. Immunol. 125, 719-726, 726.el-726.e4.
11. Orfao, A., Escribano, L., Villarrubia, J., Velasco,J. L., Cerveró, C., Ciudad, J., Navarro, J. L., San Miguel, J. F. (1996) Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. Am. J. Pathol. 149, 1493-1499.
12. Escribano, L., Orfao, A., Díaz-Agustin, B., Villarrubia, J., Cerveró, C., López, A., Marcos, M. A., Bellas, C., Femández-Cañadas, S., Cuevas, M., Sánchez, A., Velasco, J. L., Navarro, J. L., Miguel, J. F. (1998) Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91, 2731-2736.
13. Sánchez-Muñoz, L., Teodosio, C., Morgado, J. M., Escribano, L. (2011) Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders. Methods Oil Biol. 103, 333-359.
14. Escribano, L., Diaz-Agustin, B., López, A., Núñez López, R., García- Montero, A., Almeida, J., Prados, A., Angulo, M., Herrero, S., Orfao, A.; Spanish Network on Mastocytosis (REMA); Proposals of the Spanish Network on Mastocytosis (REMA) (2004) Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Cytometry B Clin. Cytom. 58, 1-8.
15. Escribano, L., Navalon, R., Nunez, R., Diaz Agustin, B., Bravo, P. (2001) Immunophenotypic analysis of human mast cells by flow cytometry. Curr. Protoc Cytom. Chapter 6, Unit 6 6.
16. Escribano, L., Ocqueteau, M., Almeida, J., Orfao, A., San Miguel, J. F. (1998) Expression of the c-kit (GDI 17) molecule in normal and malignant hematopoiesis. Iruk. Lymphoma 30, 459-466.
17. Escribano, L., Orfao, A., Viliarrubia, J., Díaz-Agustín, B., Cerveró, C., Rios, A., Velasco, J. L., Ciudad, J., Navarro, J. L., San Miguel, J. F. (1998) Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples. Anal. Cell Pathol. 16, 151-159.
18. Bühring, H. J., Seiffert, M., Giesert, C., Marxer, A., Kanz, L., Valent, P., Sano, K. (2001) The basophil activation marker defined by andbody 97A6 is identical to the ectonucleotide pyrophosphatase/ phosphodiesterase 3. Blood 97, 3303-3305.
19. Ghannadan, M., Hauswirth, A. W., Schemthaner, G. H., Müller, M. R., Klepetko, W., Schatzl, G., Sperr, W. R., Bühring, H. J., Valent, P. (2002) Detection of novel CD antigens on the surface of human mast cells and basophils. Int. Arch. Allergy Immunol. 127, 299-307.
20. Bühring, H. J., Simmons, P. J., Pudney, M., Müller, R., Jarrossay, D., van Agthoven, A., Willheim, M., Brugger, W., Valent, P., Kanz, L. (1999) The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 94, 2343-2356.
21. Escribano, L., Díaz-Agustín, B., Bellas, C., Navalón, R., Nuñez, R., Sperr, W. R., Schemthaner, G. H., Valent, P., Orfao, A. (2001) Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Iruk. lies. 25, 563-570.
22. Kirshenbaum, A. S., Kessler, S. W., Goff, J. P., Metcalfe, D. D. (1991) Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J. Immunol. 146, 1410-1415.
23. Valent, P., Spanblôchl, E., Sperr, W. R., Sillaber, C., Zsebo, K. M., Agis, H., Strobl, H., Geissler, K., Bettelheim, P., Lechner, K. (1992) Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit- ligand in long-term culture. Blood 80, 2237-2245.
24. Kirshenbaum, A. S., Goff, J. P., Semere, T., Foster, B., Scott, L. M., Metcalfe, D. D. (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD 13). Blood 94, 2333-2342.
25. Rottem, M., Okada, T., Goff, J. P., Metcalfe, D. D. (1994) Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood 84, 2489-2496.
26. Dahl, C., HofTmann, H. J., Saito, H., Schiøtz, P. O. (2004) Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy 59, 1087-1096.
27. Agis, H., Willheim, M., Sperr, W. R., Wilting, A., Krömer, E., Kabrna, E., Spanblôchl, E., Strobl, H., Geissler, K., Spittler, A, Boltz-Nitulescu, G., Majdic, O., Lechner, K., Valent, P. (1993) Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly—, CDI4—, CD17-, colony-forming cell. J. Immunol. 151,4221-4227.
28. Kempuraj, D., Saito, H., Kaneko, A., Fukagawa, K., Nakayama, M., Toru, H., Tomikawa, M., Tachimoto, H., Ebisawa, M., Akasawa, A., Miyagi, T., Kimura, H., Nakajima, T., Tsuji, K., Nakahata, T. (1999) Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93, 3338-3346.
29. Matarraz, S., Lopez, A., Barrena, S., Fernandez, C, Jensen, E., Flores, J., Bárcena, P., Rasillo, A., Sayagttes.J. M., Sanchez, M. L., Hernandez- Campo, P., Hernandez Rivas, J. M., Salvador, C., Fernandez-Mosteirín, N., Giralt, M., Perdiguer, L., Orfao, A. (2008) The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors, Isukemia 22, 1175-1183.
30. Schemthaner, G. H., Hauswirth, A. W., Baghestiinian, M., Agis, H., Ghannadan, M., Worda, C., Krauth, M. T., Printz, D., Fritsch, G., Sperr, W. R., Valent, P. (2005) Detection of differentiation- and activation- linked cell surface antigens on cultured mast cell progenitors. Allergy 60, 1248-1255.
31. Yokoi, H., Myers, A., Matsumoto, K., Crocker, P. R., Saito, H., Bochner, B. S. (2006) Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 61, 769-776.
32. Tedla, N., Lee, C. W., Borges, L., Geczy, C. L., Arm, J. P. (2008) Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells. J. Isukttf. Biol. 83, 334-343.
33. Iida, M., Matsumoto, K., Tomita, H., Nakajima, T., Akasawa, A., Ohtani N. Y., Yoshida, N. L., Matsui, K., Nakada, A., Sugita, Y., Shimizu, Y., Wakahara, S., Nakao, T., Fujii, Y., Ra, C., Saito, H. (2001) Selective down- regulation of high-affinity IgE receptor (FcepsilonRI) alpha-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 97, 1016-1022.
34. To, L. B., Haylock, D. N., Dowse, T., Simmons, P. J., Trimboli, S., Ashman, L. K.,Juttner, C. A. (1994) A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steadv-phase PR and bone marrow CD34+ cells. Blood 84, 2930-2939.
35. Kambe, N., Kambe, M., Chang, H. W., Matsui, A., Min H. K., Hussein M Oskerizian, C. A., Kochan, J., Irani, A. A., Schwartz, L. B. (2000) An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium. J. Immunol Methods 240, 101-110.
36. Dahl, C., Saito, H., Nielsen, H. V., Schiøtz, P. O. (2002) The establishment of a combined serum-free and serum-supplemented culture method of obtaining functional cord blood-derived human mast cells. J. Immunol. Methods 262, 137-143.
37. Valent, P., Schemthaner, G. H., Sperr, W. R., Fritsch, G., Agis, H., Willheim, M., Bühring, H. J., Orfao, A., Escribano, L. (2001) Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol. Rev. 179, 74-81.
38. Tachimoto, H., Hudson, S. A., Bochner, B. S. (2001) Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation. J. Allergy Clin. Immunol. 107, 302-309.
39. Xia, H. Z., Du, Z., Craig, S., Klisch, G., Noben-Trauth, N., Kochan, J. P., Huff, T. H., Irani, A. M., Schwartz, L. B. (1997) Effect of recombinant human Il-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor- dependent fetal liver-derived human mast cells. J. Immunol 159, 2911-2921.
40. Toru, H., Eguchi, M., Matsumoto, R., Yanagida, M., Yata J., Nakahata T (1998) Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation Blood 91, 187-195.
41. Tachimoto, H., Ebisawa, M., Hasegawa, T., Kashiwabara, T., Ra, C., Bochner, B. S., Miura, K., Saito, H. (2000) Reciprocal regulation of cultured human mast cell cytokine production by IL4 and IFN-gamma. J. Allergy Clin. Immunol. 106, 141-149.
42. Escribano, L., Garcia Montero, A. C., Núñez, R., Orfao, A.; Red Español de Mastocitosis (2006) Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease Allergy Clin. North Am. 26, 535-547.
43. Núňez-López, R., Escribano, L., Schemthaner, G. H., Prados, A., Rodríguez-González, R., Díaz-Agustín, B., López, A., Hauswirth, A. Valent, P., Almeida, J., Bravo, P., Orfao, A. (2003) Overexpression of complement receptors and related antigens on the surface of hone marrow mast cells in patients with systemic mastocytosis. Br. J. Haematol 120, 257-265.
44. Escribano, L., Díaz-Agustín, B., Núñez, R., Prados, A., Rodriguez, R Orfao, A. (2002) Abnormal expression of CD antigens in mastocvtośk Int. Arch. Allergy Immunol. 127, 127-132.
45. Forsythe, P., Ennis, M. (2000) Clinical consequences of mast cell heterogeneity. Inflamm. Res. 49, 147-154.
46. Welle, M. (1997) Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61, 233-245.
47. Oskeritzian, C. A., Zhao, W., Min, H. K., Xia, H. Z., Pozez, A., Kiev I Schwartz, L. B. (2005) Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J. Allerm Clin Immunol. 115, 1162-1168.
48. Andersson, C. K., Mori, M., Bjermer, L., Lõfdahl, C. G., Frjefält, J. S. (2009) Novel site-specific mast cell subpopulations in the human lung. Thorax 64, 297-305.
49. Galli, S. J., Grimbaldeston, M., Tsai, M. (2008) Immunomodulatory mas. cells: negative, as well as positive, regulators of immunity Nat Rev 8, 478-486.
50. Grützkau, A., Smorodchenko, A., Lippert, U., Kirchhof, L., Artuc M Henz, B. M. (2004) LAMP-1 and I AMP-2, but not I AMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry 61, 62-68.
51. Furuno, T., Teshima, R., Kitani, S., Sawada, J., Nakanishi, M. (1996) Surface expression of CD63 antigen (ADI antigen) in P8I5 mastocytoma cells by transfected IgE receptors. Biochem. Biophys. Res Commun. 219, 740-744.
52. Hennersdorf, F., Florian, S., Jakob, A., Baumgartner, K., Sonneck, K. Nordheim, A., Biedermann, T., Valent, P., Bühring, H. J. (2005) Identification of CD13, CD107a, and CD164 as novel basophil-activatio markers and dissection of two response patterns in time kinetics of dependent upregulation. Cell Res. 15, 325-335.
53. Larson, D., Mitre, E. (2012) Histamine release and surface CD200R1 staining as sensitive methods for assessing murine mast cell activation. J. Immunol Methods 379, 15-22.
54. Ghannadan, M., Baghestanian, M., Wimazal, F., Eisenmenger, M., Latal, D., Kargül, G., Walchshofer, S., Sillaber, C., Lechner, K., Valent, P. (1998) Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J. Invest. Dermatol 111, 689-695.
55. Woolhiser, M. R., Okayama, Y., Gilfìllan, A. M., Metcalfe, D. D. (2001) IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur. J. Immunol. 31, 3298-3307.
56. Henz, B. M., Maurer, M., Lippert, U., Worm, M., Babina, M. (2001) Mast cells as initiators of immunity and host defense. Exp. Dermatol. 10, 1-10.
57. Wong, G. H., Clark-Lewis, I., McKimm-Breschkin, J. L., Schrader, J. W. (1982) Interferon-gamma-like molecule induces la antigens on cultured mast cell progenitors. Proc. Natl. Acad. Sri. USA 79, 6989-6993.
58. Weber, S., Babina, M., Feller, G., Henz, B. M. (1997) Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMG1 cells. Stand. J. Immunol. 45, 471-481.
59. Orfao, A., Garcia-Montero, A. C., Sanchez, L., Escribano, L.; REMA (2007) Recent advances in the understanding of mastocy tosis: the role of KIT mutations. Br.J. Haematol 138, 12-30.
60. Díaz-Agustín, B., Escribano, L., Bravo, P., Herrera, S., Nuñez, R., Navalón, R., Navarro, L., Torrelo, A., Cantalapiedra, A., Del Castillo, L., Villarrubia, J., Navarro,J. L., San Miguel.J. F., Orfao, A. (1999) The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br. J. Haematol. 106, 400-405.
61. Escribano, L., Orfao, A., Diaz Agustín, B., Cerveró, C., Herrero, S., Villarrubia, J., Bravo, P., Torrelo, A., Montero, T., Valdemoro, M., Velasco,J. L., Navarro,J. L., San Miguel J. F. (1998) Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 34, 223-228.
62. Valent, P., Sotlar, K., Sperr, W. R., Escribano, L., Yavuz, S., Reiter, A., George, T. I., Kluin-Nelemans, H. C., Hermine, O., Butterfield, J. H., Hãgglund, H., Ustun, C., Homick, J. L., Triggiani, M., Radia, D., Akin, C., Hartmann, K., Gotlib, J., Schwartz, L. B., Verstovsek, S., Orfao, A, Metcalfe, D. D., Arock, M., Horny, H. P. (2014) Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann. Oncol. 25, 1691-1700.
63. Sotlar, K., Colak, S., Bache, A., Berezowska, S., Krokowski, M., Bültmann, B., Valent, P., Horny, H. P. (2010) Variable presence of K1TDH16V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J. Pathol. 220, 586-595.
64. Bibi, S., Arslanhan, M. D., Iangenfeld, F., Jeanningros, S., Cemy- Reiterer, S., Hadzijusufovic, E., Tchertanov, L., Moriggl, R., Valent, P., Arock, M. (2014) Cooperating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy. Haematologirn 99, 417-429.
65. Escribano, L., Alvarez-Twose, I., Sánchez-Muñoz, L., Garcia-Montero, A., Núñez, R., Almeida, J., Jara-Acevedo, M., Teodósio, C., García- Cosío, M., Bellas, C., Orfao, A. (2009) Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J. Allergy Clin. Immunol. 124, 514-521.
66. Lim, K. H., Tefferi, A., Lasho, T. L., Finke, C., Patnaik, M., Butterfield, J. H., McClure, R. F., Li C. Y., Pardanani, A. (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113, 5727-5736.
67. Pardanani, A., Kimlinger T., Reeder, T., Li, C. Y., Tefferi, A. (2004) Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk. Res. 28, 777-783.
68. Escribano, L., Orfao, A., Villarrubia, J., Martín, F., Madniga, J. I., Cuevas, M., Velasco, J. L., Rios, A., San Miguel J. F. (1997) Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 30, 98-102.
69. Escribano, L., Akin, C., Castells, M., Orfao, A., Metcalfe, D. D. (2002) Mastocytosis: current concepts in diagnosis and treatment. Ann. Hematoi 81, 677-690.